Anti-Sia-lb (anti-Gd) cold agglutinins bind the domain NeuNAc alpha2-3Gal in sialyl Lewis(x), sialyl Lewis(a), and related carbohydrates on nucleated cells and in soluble cancer-associated mucins.
Anti-Sia-lb (formerly anti-Gd) cold agglutinins (CAs) recognize sialylated carbohydrates on both adult and neonate red blood cells (RBCs). RBC CA activity inhibition experiments reported here indicate that the domain NeuNAc alpha2-3Gal, as found in sialyllactose, synthetic sialyl(s) Lewis(Le)(x) and sLe(a), sialyllactosamine, sialyl-fucosyllactose, and nonfucosylated sLe(a), constitutes the minimal epitope for these CAs, implicating that these autoantibodies could be able to bind this domain in sLe(x) and sLe(a) and related carbohydrates expressed on nucleated cells and in soluble cancer-related mucins. The following data obtained with the previously characterized monoclonal IgMk anti-Sia-lb CA, GAS, show that this is the case. GAS epitope expression among leukocytes that lack sLe(a) parallels that of sLe(x) determinant as detected by mouse monoclonal antibodies (MoAbs), especially MoAb KM-93. It is also found on epithelial malignant cells bearing both sLe(x) and sLe(a). GAS epitope on these nucleated cells, (1) like that present on RBC, is abolished by sialidase, unaffected by proteases, and inhibited by sialyllactose; and (2) is overlapping and/or proximal to that recognized by anti-sLe(x) MoAb, CSLEX-1, and KM-93. Moreover, CAGAS binds soluble cancer-associated mucins bearing sLe(x) and sLe(a) determinants. This binding is inhibited by sialyllactose and these mucins inhibit the RBC CA activity of CAGAS. The possible significance of anti-Sia-lb (anti-Gd) CAs as autoantibodies directed to carbohydrate ligands of host adhesion molecules that might be receptors of microbial adhesins of some CA-inducing pathogens is discussed.
Gallart
T
T
Service of Immunology, Hospital Clínic Universitari, Barcelona, Spain.
Roelcke
D
D
Blay
M
M
Pereira
A
A
Martínez
A
A
Massó
O
O
Viñas
O
O
Cid
M
M
Esparza
J
J
Molina
R
R
Barceló
J
J
D000373:Agglutinins / Q000378:metabolism*; D000606:Amino Sugars / Q000378:metabolism; D000818:Animals; D000951:Antigens, Neoplasm / Q000378:metabolism*; D001323:Autoantibodies / Q000378:metabolism*; D001665:Binding Sites; D014408:Biomarkers, Tumor; D002240:Carbohydrate Sequence; D003080:Cold Temperature; D003450:Cryoglobulins; D000939:Epitopes / Q000378:metabolism; D006388:Hemagglutinins / Q000378:metabolism*; D007962:Leukocytes / Q000378:metabolism; D051379:Mice; D008969:Molecular Sequence Data; D009077:Mucins / Q000378:metabolism*; D009844:Oligosaccharides / Q000378:metabolism*; D011134:Polysaccharides / Q000378:metabolism; D011961:Receptors, Fc / Q000378:metabolism; D000080506:Sialyl Lewis X Antigen; D014407:Tumor Cells, Cultured
D000373:Agglutinins; D000606:Amino Sugars; D000951:Antigens, Neoplasm; D001323:Autoantibodies; D014408:Biomarkers, Tumor; D003450:Cryoglobulins; D000939:Epitopes; D006388:Hemagglutinins; D009077:Mucins; D009844:Oligosaccharides; D011134:Polysaccharides; D011961:Receptors, Fc; D000080506:Sialyl Lewis X Antigen; C029443:cold agglutinins; C062923:N-acetylneuraminosyl(alpha2-6)lactosamine; C042476:sialylfucosyllactosaminoglycan